BMC Psychiatry (May 2023)

Depression after stoma surgery: a systematic review and meta-analysis

  • Joshua G. Kovoor,
  • Jonathan Henry W. Jacobsen,
  • Brandon Stretton,
  • Stephen Bacchi,
  • Aashray K. Gupta,
  • Brayden Claridge,
  • Matthew V. Steen,
  • Ameya Bhanushali,
  • Lorenz Bartholomeusz,
  • Suzanne Edwards,
  • Gayatri P. Asokan,
  • Gopika Asokan,
  • Amanda McGee,
  • Christopher D. Ovenden,
  • Joseph N. Hewitt,
  • Markus I. Trochsler,
  • Robert T. Padbury,
  • Seth W. Perry,
  • Ma-Li Wong,
  • Julio Licinio,
  • Guy J. Maddern,
  • Peter J. Hewett

DOI
https://doi.org/10.1186/s12888-023-04871-0
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Background Depression is the leading cause of global disability and can develop following the change in body image and functional capacity associated with stoma surgery. However, reported prevalence across the literature is unknown. Accordingly, we performed a systematic review and meta-analysis aiming to characterise depressive symptoms after stoma surgery and potential predictive factors. Methods PubMed/MEDLINE, Embase, CINAHL and Cochrane Library were searched from respective database inception to 6 March 2023 for studies reporting rates of depressive symptoms after stoma surgery. Risk of bias was assessed using the Downs and Black checklist for non-randomised studies of interventions (NRSIs), and Cochrane RoB2 tool for randomised controlled trials (RCTs). Meta-analysis incorporated meta-regressions and a random-effects model. Registration: PROSPERO, CRD42021262345. Results From 5,742 records, 68 studies were included. According to Downs and Black checklist, the 65 NRSIs were of low to moderate methodological quality. According to Cochrane RoB2, the three RCTs ranged from low risk of bias to some concerns of bias. Thirty-eight studies reported rates of depressive symptoms after stoma surgery as a proportion of the respective study populations, and from these, the median rate across all timepoints was 42.9% 42.9% (IQR: 24.2–58.9%). Pooled scores for respective validated depression measures (Hospital Anxiety and Depression Score (HADS), Beck Depression Inventory (BDI), and Patient Health Questionnaire-9 (PHQ-9)) across studies reporting those scores were below clinical thresholds for major depressive disorder according to severity criteria of the respective scores. In the three studies that used the HADS to compare non-stoma versus stoma surgical populations, depressive symptoms were 58% less frequent in non-stoma populations. Region (Asia–Pacific; Europe; Middle East/Africa; North America) was significantly associated with postoperative depressive symptoms (p = 0.002), whereas age (p = 0.592) and sex (p = 0.069) were not. Conclusions Depressive symptoms occur in almost half of stoma surgery patients, which is higher than the general population, and many inflammatory bowel disease and colorectal cancer populations outlined in the literature. However, validated measures suggest this is mostly at a level of clinical severity below major depressive disorder. Stoma patient outcomes and postoperative psychosocial adjustment may be enhanced by increased psychological evaluation and care in the perioperative period.

Keywords